(Q40916859)

24 September 2017

1 reference

title

Current status of cancer immunodetection with radiolabeled human monoclonal antibodies (English)

1 reference

24 September 2017

De Jager R

1

1 reference

24 September 2017

Abdel-Nabi H

2

1 reference

24 September 2017

Serafini A

3

1 reference

24 September 2017

Pecking A

4

1 reference

24 September 2017

Klein JL

5

1 reference

24 September 2017

Hanna MG Jr

6

1 reference

24 September 2017

publication date

1 April 1993

1 reference

Seminars in Nuclear Medicine

24 September 2017

published in

1 reference

24 September 2017

volume

23

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

165-179

1 reference

Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Specific detection of anti-idiotypic immune responses in cancer patients treated with murine monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Generation of a recombinant mouse-human chimaeric monoclonal antibody directed against human carcinoembryonic antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Human monoclonal antibody production. Current status and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Human hybridomas from patients with malignant disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Generation of human monoclonal antibodies against colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

A human monoclonal antibody produced by in vitro sensitization of human lymphocytes with an antigen from urine of a sarcoma patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Alloimmunization with cultured human stomach cancer cell lines and the establishment of human-human hybridomas producing monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Antibodies from EB-virus-transformed lymphocytes of lymph nodes adjoining lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Immunohistological characterization of human monoclonal antibody against lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Human-human hybridoma producing monoclonal antibodies against colorectal cancer-associated antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

The immunohistochemical reactivity of a human monoclonal antibody with tissue sections of human mammary tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Breast cancer imaging with In-111 human IgM monoclonal antibodies: preliminary studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Internal antigens accessible in breast cancer: implications for tumor targeting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Radio-immunolocalization in Nude Mice Using Anticytokeratin Monoclonal Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Toxicity, immunogenicity, and tumor radioimmunodetecting ability of two human monoclonal antibodies in patients with metastatic colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Tumour localisation with 131I-labelled human IgM monoclonal antibody 16.88 in advanced colorectal cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Human IgM monoclonal antibody 16.88: pharmacokinetics and immunogenicity in colorectal cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Monoclonal anitbodies in the lymphatics: toward the diagnosis and therapy of tumor metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

7 January 2021

Immunolymphoscintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

Immunoscintigraphy for detection of lymph node metastases from breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

New chelating agent for attaching indium-111 to monoclonal antibodies: in vitro and in vivo evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980096-0

10.1016/S0001-2998(05)80096-0

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference